Myelofibrosis predicts deep molecular response 4.5 in chronic myeloid leukaemia patients initially treated with imatinib: An extensive, multicenter and retrospective study to develop a prognostic model.
Zeng T, Yang X, Wang Y, Wu D, Feng W, Lu Y, Zhu X, Liu L, Zhou M, Zhang L, Shao Y, Qian H, Zhu F, Chen Y, Cao D, Huang L, Feng X, Chen L, Zhang G, Le J, Zhu W, Xia Y, Han Y, Jia Y, Tian G, Zhou H, Xu L, Yin X, Tang Q, Zhang Y, Yao G, Lang X, Zhang K, Zhou X, Guo J, Tu J, Zhao J, Wu G, Zhang H, Wu X, Luo Q, Cao L, Chu B, Jiang W, Wu H, Huang L, Hu M, He M, Zhu J, Tong H, Jin J, Huang J.
Zeng T, et al. Among authors: jia y.
Clin Transl Med. 2024 Nov;14(11):e70101. doi: 10.1002/ctm2.70101.
Clin Transl Med. 2024.
PMID: 39576229
Free PMC article.
No abstract available.